Dalakas MC, Hohlfeld R: Polymyositis and dermatomyositis. Lancet. 2003, 362: 971-982. 10.1016/S0140-6736(03)14368-1.
Article
CAS
PubMed
Google Scholar
De Paepe B, Creus KK, De Bleecker JL: Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2009, 21: 610-616. 10.1097/BOR.0b013e3283317b31.
Article
CAS
PubMed
Google Scholar
Filková M, Haluzík M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133: 157-170. 10.1016/j.clim.2009.07.013.
Article
PubMed
Google Scholar
Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.
Article
CAS
PubMed
Google Scholar
Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP: Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab. 2007, 92: 2272-2279. 10.1210/jc.2006-2545.
Article
CAS
PubMed
Google Scholar
Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004, 1: e45-10.1371/journal.pmed.0010045.
Article
PubMed Central
PubMed
Google Scholar
Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003, 309: 286-290. 10.1016/j.bbrc.2003.07.003.
Article
CAS
PubMed
Google Scholar
Nagaev I, Bokarewa M, Tarkowski A, Smith U: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE. 2006, 1: e31-10.1371/journal.pone.0000031.
Article
PubMed Central
PubMed
Google Scholar
Mu H, Ohashi R, Yan S, Chai H, Yang H, Lin P, Yao Q, Chen C: Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006, 70: 146-157. 10.1016/j.cardiores.2006.01.015.
Article
CAS
PubMed
Google Scholar
Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003, 108: 736-740. 10.1161/01.CIR.0000084503.91330.49.
Article
CAS
PubMed
Google Scholar
Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun. 2004, 314: 415-419. 10.1016/j.bbrc.2003.12.104.
Article
CAS
PubMed
Google Scholar
Tomasová Studynková J, Charvát F, Jarosová K, Vencovsky J: The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford). 2007, 46: 1174-1179. 10.1093/rheumatology/kem088.
Article
Google Scholar
Dalakas MC: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991, 325: 1487-1498.
Article
CAS
PubMed
Google Scholar
Amato AA, Griggs RC: Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003, 61: 288-289. 10.1212/WNL.61.3.288.
Article
PubMed
Google Scholar
Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL: Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005, 84: 231-249. 10.1097/01.md.0000173991.74008.b0.
Article
Google Scholar
Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS): International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic infl ammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology(Oxford). 2004, 43: 49-54. 10.1093/rheumatology/keg427.
Article
CAS
Google Scholar
Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE: Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010, 62: 465-472. 10.1002/acr.20035.
Article
Google Scholar
Schäffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Schölmerich J, Müller-Ladner U, Gay S: Adipocytokines in synovial fluid. JAMA. 2003, 290: 1709-1710. 10.1001/jama.290.13.1709-c.
Article
PubMed
Google Scholar
Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M: Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007, 66: 458-463.
Article
PubMed Central
CAS
PubMed
Google Scholar
Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K: The serum evels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006, 24: 698-701.
CAS
PubMed
Google Scholar
Almehed K, d'Elia HF, Bokarewa M, Carlsten H: Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther. 2008, 10: R15-10.1186/ar2366.
Article
PubMed Central
PubMed
Google Scholar
Baker JF, Morales M, Qatanani M, Cucchiara A, Nackos E, Lazar MA, Teff K, Von Feldt JM: Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification. J Rheumatol. 2011, 38: 2369-2375. 10.3899/jrheum.110237.
Article
CAS
PubMed
Google Scholar
Karalaki M, Fili S, Philippou A, Koutsilieris M: Muscle regeneration: cellular and molecular events. In Vivo. 2009, 23: 779-796.
CAS
PubMed
Google Scholar
Tidball JG, Villalta SA: Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R1173-1187. 10.1152/ajpregu.00735.2009.
Article
PubMed Central
CAS
PubMed
Google Scholar
Loell I, Lundberg IE: Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?. J Intern Med. 2011, 269: 243-257. 10.1111/j.1365-2796.2010.02334.x.
Article
CAS
PubMed
Google Scholar
Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.
Article
CAS
PubMed
Google Scholar
Liprandi A, Bartoli C, Figarella-Branger D, Pellissier JF, Lepidi H: Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol. 1999, 97: 642-648. 10.1007/s004010051041.
Article
CAS
PubMed
Google Scholar
Lundberg I, Kratz AK, Alexanderson H, Patarroyo M: Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticoid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2000, 43: 336-348. 10.1002/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V.
Article
CAS
PubMed
Google Scholar
Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM: Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009, 60: 3436-3446. 10.1002/art.24936.
Article
CAS
PubMed
Google Scholar
Mackiewicz Z, Hukkanen M, Povilenaite D, Sukura A, Fonseca JE, Virtanen I, Konttinen YT: Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies. Clin Exp Rheumatol. 2003, 21: 41-48.
CAS
PubMed
Google Scholar
Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, Kim DS, Baek SH, Lee SH, Lee JH, Kim HY, Kim SI: Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol. 2010, 29: 273-279. 10.1007/s10067-009-1316-7.
Article
PubMed Central
PubMed
Google Scholar
Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI: Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010, 14: 1419-1431.
Article
PubMed Central
CAS
PubMed
Google Scholar
Greenberg SA: Dermatomyositis and type 1 interferons. Curr Rheumatol Rep. 2010, 12: 198-203. 10.1007/s11926-010-0101-6.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tournadre A, Lenief V, Eljaafari A, Miossec P: Immature muscle precursors are a source of interferon-β in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 2012, 64: 533-541.
Article
CAS
PubMed
Google Scholar